Efficacy and safety of pertuzumab for HER2 positive metastatic breast cancer: a single institution experience

被引：0
|
作者：
Hara, Fumikata [1 ]
Aogi, Kenjiro [1 ]
Takashima, Seiki [1 ]
机构：
[1] Shikoku Canc Ctr, Breast Oncol, Matsuyama, Ehime, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-5-1
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [41] Lapatinib-based therapy in heavily pretreated HER2-positive metastatic breast cancer: a single institution experience
    Crivellari, Diana
    Spazzapan, Simon
    Lombardi, Davide
    Militello, Loredana
    Torrisi, Elena
    Russo, Alessia E.
    Sorio, Roberto
    Talamini, Renato
    Miolo, Gianmaria
    Carli, Paolo
    Veronesi, Andrea
    [J]. TUMORI JOURNAL, 2012, 98 (01): : 33 - 38
  • [42] Lapatinib plus capecitabine in highly pretreated HER2-positive metastatic breast cancer: A single-institution experience
    Crivellari, D.
    Spazzapan, S.
    Magri, M.
    Frustaci, S.
    Talamini, R.
    Lombardi, D.
    Torrisi, E.
    Scalone, S.
    Miolo, G.
    Veronesi, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Amar, Surabhi
    Moreno-Aspitia, Alvaro
    Perez, Edith A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (01) : 1 - 7
  • [44] Issues and controversies in the treatment of HER2 positive metastatic breast cancer
    Surabhi Amar
    Alvaro Moreno-Aspitia
    Edith A. Perez
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 1 - 7
  • [45] Triple HER2-blockade with lapatinib, trastuzumab, and pertuzumab for treatment of HER2 positive metastatic breast cancer with lymphangitic carcinomatosis: A case study
    Nozawa, Kazuki
    Takatsuka, Daiki
    Endo, Yuka
    Horisawa, Nanae
    Ozaki, Yuri
    Kataoka, Ayumi
    Kotani, Haruru
    Yoshimura, Akiyo
    Hattori, Masaya
    Sawaki, Masataka
    Iwata, Hiroji
    [J]. CURRENT PROBLEMS IN CANCER: CASE REPORTS, 2022, 7
  • [46] Outcome of non-metastatic HER2 positive breast cancer
    Mehmood, T.
    Rashid, A.
    Irfan, N.
    Hameed, S.
    Shah, M. Ali
    Jamshed, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : S54 - S54
  • [47] Significance of HER2 in Microinvasive Breast Carcinoma A Single Academic Institution Experience
    Zhang, Huina
    Moisini, Ioana
    Turner, Bradley M.
    Wang, Xi
    Dhakal, Ajay
    Yang, Qi
    Kovar, Sierra
    Schiffhauer, Linda M.
    Hicks, David G.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2021, 156 (01) : 155 - 165
  • [48] Significance of HER2 in Microinvasive Carcinoma of Breast: A Single Academic Institution Experience
    Zhang, Huina
    Moisini, Ioana
    Turner, Bradley
    Wang, Xi
    Hicks, David
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 291 - 292
  • [49] Significance of HER2 in Microinvasive Carcinoma of Breast: A Single Academic Institution Experience
    Zhang, Huina
    Moisini, Ioana
    Turner, Bradley
    Wang, Xi
    Hicks, David
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 291 - 292
  • [50] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    [J]. CANCER RESEARCH, 2023, 83 (05)
12345